Sign in

You're signed outSign in or to get full access.

TC

TREDEGAR CORP (TG)·Q4 2024 Earnings Summary

Executive Summary

  • Q4 2024 delivered sequential improvement: consolidated EBITDA from ongoing operations rose to $11.1M vs. $10.1M in Q3, driven by stronger Bonnell Aluminum (Aluminum Extrusions) and PE Films; GAAP EPS was a loss of $(0.21) while ongoing EPS was $0.06, reflecting non-GAAP normalization of special items .
  • Segment performance: Aluminum Extrusions EBITDA $9.7M (+56% q/q; +21% y/y) on higher volumes and contribution margin; PE Films EBITDA $7.6M (+29% q/q; +68% y/y) as surface protection continued to recover .
  • Balance sheet and leverage improved materially post-Terphane sale, with net debt down to $54.8M and net leverage ratio at 1.1x vs. 3.7x in 2023; availability under the ABL was ~$44M at year-end .
  • Policy tailwind: Section 232 aluminum tariffs increased to 25% effective March 12, 2025 and broadened to downstream products; management expects this to support domestic extruders, a potential stock reaction catalyst as macro policy shifts aid pricing power and share recapture .
  • No explicit revenue/EPS guidance provided; 2025 segment capex and D&A plans outlined (Bonnell: $17M capex; PE Films: $3M), indicating operational investment focus over near-term top-line targets .

What Went Well and What Went Wrong

What Went Well

  • Aluminum Extrusions volume and orders strengthened: sales volume up 8.8% y/y to 35.8M lbs; net new orders +23% y/y; open orders rose to ~17M lbs (vs. 14M y/y), supporting a recovery narrative .
  • PE Films recovery continued: EBITDA from ongoing operations $7.6M in Q4 (+$3.1M y/y) on stronger surface protection volumes and mix, plus cost improvements .
  • Leverage reset: net leverage ratio improved to 1.1x (from 3.7x), aided by Terphane divestiture proceeds and operating cash flow; availability under ABL ~$44M at YE, bolstering liquidity .

Management quotes:

  • “Both businesses finished 2024 with solid performances in the typically seasonally low fourth quarter.” – CEO John Steitz .
  • “Net new orders have continued to grow at Bonnell Aluminum so far in 2025. PE Films results are encouraging as well.” – CEO John Steitz .
  • “We support actions to increase the Section 232 tariffs... and to apply the tariffs to downstream products like the extrusions that we produce.” – CEO John Steitz .

What Went Wrong

  • GAAP hit from goodwill impairment: $13.3M pretax write-off at Bonnell’s Clearfield unit pressured Q4 GAAP results (after-tax $10.4M) despite positive ongoing earnings; highlights slower-than-expected full recovery of customer volumes post-pandemic disruptions .
  • LIFO/SG&A pressures: LIFO charge of $1.2M (vs. $0.9M benefit y/y) and higher SG&A (+$1.3M, chiefly incentives) diluted Aluminum Extrusions EBITDA flow-through .
  • Mixed end-market signals: Automotive volumes fell 21% y/y in Q4, and non-residential B&C volume slightly declined y/y, underscoring uneven demand across sub-markets .

Financial Results

Consolidated Quarterly Snapshot

Metric (USD)Q2 2024Q3 2024Q4 2024
Sales ($MM)$190.235 $182.051 $154.049
Net Income from Continuing Ops ($MM)$8.792 $(3.946) $(7.339)
Diluted EPS – Continuing Ops ($)$0.26 $(0.11) $(0.21)
Net Income from Ongoing Ops ($MM)$15.9 $16.0 $2.0
Ongoing EPS – Diluted ($)$0.30 $0.01 $0.06
Consolidated EBITDA from Ongoing Ops ($MM)$22.6 $10.1 $11.1
EBITDA Margin % (EBITDA ÷ Sales)11.9% (22.6/190.235) 5.6% (10.1/182.051) 7.2% (11.1/154.049)

Notes: “Ongoing” excludes special items per company reconciliation.

Segment Breakdown

Segment Metric (USD)Q2 2024Q3 2024Q4 2024
Aluminum Extrusions Net Sales ($MM)$119.413 $115.717 $122.462
Aluminum Extrusions EBITDA – Ongoing ($MM)$12.907 $6.177 $9.733
PE Films Net Sales ($MM)$29.197 $24.879 $26.388
PE Films EBITDA – Ongoing ($MM)$10.133 $5.876 $7.573

Operating KPIs

KPIQ2 2024Q3 2024Q4 2024
Aluminum Extrusions Sales Volume (lbs, MM)34.9 34.6 35.8
Open Orders (lbs, MM)~14 ~15.5 ~17
Net New Orders (% y/y)+17% +27% +23%
PE Films Sales Volume (lbs, MM)10.5 9.6 9.1

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Bonnell Aluminum CapexFY 2024 (prev) vs. FY 2025 (curr)$8M FY24 (productivity $4M; continuity $4M) $17M FY25 (productivity $5M; continuity $12M) Raised (higher continuity spend)
Bonnell DepreciationFY 2024 (prev) vs. FY 2025 (curr)~$16M FY24 ~$16M FY25 Maintained
Bonnell AmortizationFY 2024 (prev) vs. FY 2025 (curr)~$2M FY24 ~$2M FY25 Maintained
PE Films CapexFY 2024 (prev) vs. FY 2025 (curr)$2M FY24 $3M FY25 (productivity $2M; continuity $1M) Raised
PE Films DepreciationFY 2024 (prev) vs. FY 2025 (curr)~$5M FY24 ~$5M FY25 Maintained
PE Films AmortizationFY 2024 (prev) vs. FY 2025 (curr)None None Maintained
Tariffs (Section 232)Effective 3/12/202510% aluminum imports 25% aluminum imports; scope expanded to downstream products, exclusions revoked Raised/applicability expanded
Dividends/Tax Rate/Revenue/EPS GuidanceFY 2025Not providedNot providedNo change disclosed

Earnings Call Themes & Trends

TopicPrevious Mentions (Q2 2024)Previous Mentions (Q3 2024)Current Period (Q4 2024)Trend
Trade case & tariffsDOC prelim anti-dumping determinations; hopeful for share recapture USITC negative injury vote; coalition evaluating next steps Section 232 raised to 25% and extended to downstream; management supportive Policy tailwind improving
PE Films demand restockingExceptional H1’24 surface protection restock; expected moderation Moderation began; still better than anticipated Q4 seasonally low yet stronger y/y; continued efficiencies Normalizing at higher base
Aluminum Extrusions ordersNet new orders +17% y/y; open orders ~14M lbs Net new orders +27% y/y; open orders ~15.5M lbs Net new orders +23% y/y; open orders ~17M lbs Sequential improvement
ERP/MES programReorganized; extended timeline to 2025 earliest go-live Timing uncertain; spend ~$21M to date Ongoing program context maintained Extended implementation
Debt/leverage & liquidityNet debt ~$133.3M; ABL availability ~$36M Net debt ~$136.8M; availability ~$30–$38M pro forma Net debt $54.8M; availability ~$44M; leverage 1.1x Material improvement
Terphane divestiturePending regulatory review (Brazil) Closed Nov 1, 2024; $78M proceeds at closing; $7M expected escrow Post-closing settlement $9.8M received in Q1’25 Completed; cash inflows

Management Commentary

  • Strategic posture: “Our balance sheet was strong at the end of 2024 with a net leverage ratio of 1.1x… due to the cyclical recovery… and the completion of the sale of Terphane” – CEO John Steitz .
  • Policy advocacy: “We support actions to increase the Section 232 tariffs… [and] apply the tariffs to downstream products like the extrusions that we produce” – CEO John Steitz .
  • Segment tone: “Net new orders have continued to grow at Bonnell Aluminum… PE Films results are encouraging as well” – CEO John Steitz .
  • Asset impairment context: Clearfield goodwill write-off reflects slower-than-anticipated profit recovery to pre-pandemic levels due to customer sourcing shifts and import competition .

Q&A Highlights

  • No Q4 earnings call transcript available in the document catalog; management commentary is from the earnings press release and 8-K materials .

Estimates Context

  • Wall Street consensus (S&P Global) for Q4 2024 EPS/Revenue/EBITDA was unavailable due to SPGI access limitations (Daily Request Limit exceeded). As a result, comparisons to consensus cannot be provided at this time.
  • Implication: With stronger-than-expected segment EBITDA momentum and tariff policy tailwinds, sell-side models may need to revisit Aluminum Extrusions volume/mix assumptions and PE Films margin durability; however, we cannot quantify revisions without S&P Global data.

Key Takeaways for Investors

  • Recovery intact: Sequential EBITDA from ongoing operations improved, with Aluminum Extrusions volumes and orders trending up; watch specialty products demand and B&C pipeline to sustain momentum .
  • PE Films resilience: Post-restock moderation still yields robust y/y growth; efficiencies and mix support margins—monitor display end-market cycles for sustainability .
  • Leverage reset is a catalyst: Net leverage at 1.1x and ~$44M ABL availability expands strategic flexibility; additional $9.8M settlement proceeds received Q1’25 bolster liquidity .
  • Policy tailwinds: Section 232 tariff increase and scope expansion could improve domestic pricing power and deter circumvention via downstream imports; a potential medium-term margin uplift for Bonnell .
  • Non-GAAP vs GAAP: Goodwill impairment drove GAAP loss in Q4, but ongoing operations remain profitable; focus on cash-generation metrics and ongoing EBITDA to gauge core performance .
  • Capex targeted to continuity/productivity: Elevated 2025 capex at Bonnell and modest increase at PE Films indicate investment in reliability and efficiency; watch returns on these deployments .
  • Risk checks: Automotive demand softness and LIFO charges remain watch items; ERP/MES timing still extended—execution matters for operational improvement .

Sources: Tredegar Q4 2024 8-K and press release, Q3 and Q2 8-Ks and press releases, and company news on Terphane sale .